Shortage Watch Free FDA drug-shortage watch

← all medications

Cetrorelix Acetate Injection

Category: Reproductive

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Nov 13, 2025 · First posted: Nov 13, 2025 · 1 manufacturers, 1 listed presentations

As of Nov 13, 2025, the FDA lists Cetrorelix Acetate Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Cetrorelix Acetate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08)
NDC 0480-5795-08		 Teva Pharmaceuticals USA, Inc. Not specified Discontinuation of the manufacture of the drug

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Cetrorelix Acetate Injection (FDA data as of Nov 13, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Cetrorelix Acetate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Cetrorelix Acetate Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/cetrorelix-acetate-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).